Loading clinical trials...
Loading clinical trials...
A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy
Conditions
Interventions
AEZS-108
AEZS-108 at MTD
Locations
2
United States
University of Miami Miller School of Medicine
Miami, Florida, United States
Univerity of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
November 1, 2010
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
March 15, 2018
NCT07061964
NCT05987241
NCT06349642
NCT07452432
NCT06668493
NCT06809140
Lead Sponsor
AEterna Zentaris
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions